Elena E. Arellano
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.
Journal: Open forum infectious diseases
Published: September 24, 2025
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.
Journal: American journal of hematology
Published: July 22, 2025
The Potential of Extracellular Microvesicle MicroRNAs in Precapillary Pulmonary Hypertension.
Journal: American journal of respiratory cell and molecular biology
Published: March 05, 2025
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.
Journal: American journal of hematology
Published: October 16, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: May 21, 2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.
Journal: Frontiers in oncology
Published: February 21, 2024
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Journal: Haematologica
Published: December 12, 2023
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Journal: EClinicalMedicine
Published: November 22, 2023
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Journal: Leukemia & lymphoma
Published: November 15, 2023
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Journal: Infection
Published: November 10, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
Journal: Viruses
Published: September 14, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Journal: Hematological oncology
Published: June 27, 2023
Last Updated: 09/26/2026